Immunogenicity and safety of ‘Comvigen’, a bivalent SARS-CoV-2 vaccine, in comparison to Comirnaty bivalent vaccine in Thailand: a phase 2, non-inferiority randomised trial

Covid-19 Pandemic Emergency Fund granted by Thailand's National Economic and Social Development Council provided major funding. Supplementary funding was provided by National Vaccine Institute (NVI), Thailand; Center of Excellence in Vaccine Research and Development (Chula VRC), Faculty of Medicine, Chulalongkorn University; Chulalongkorn University Second Century Fund (C2F); BioNet-Asia and Public Donation through Covid-19 vaccine development fund of the Faculty of Medicine, Chulalongkorn University and the Thai Red Cross Society, Thailand.

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Southeast Asia
Published
2025-08-18
DOI
https://doi.org/10.1016/j.lansea.2025.100650
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunogenicity and safety of ‘Comvigen’, a bivalent SARS-CoV-2 vaccine, in comparison to Comirnaty bivalent vaccine in Thailand: a phase 2, non-inferiority randomised trial

Rapisa Nantanee, Wasin Buasri, Daraporn Pittayakhajonwut, Mukesh Chauhan et al.
The Lancet Regional Health - Southeast Asia
SARS-CoV-2 and COVID-19 Research
article

Immunogenicity and safety of ‘Comvigen’, a bivalent SARS-CoV-2 vaccine, in comparison to Comirnaty bivalent vaccine in Thailand: a phase 2, non-inferiority randomised trial

Rapisa Nantanee, Wasin Buasri, Daraporn Pittayakhajonwut, Mukesh Chauhan, Sivaporn Gatechompol, Souad Mansouri, Roongrawee Sriaksorn, Terapong Tantawichien, Apicha Mahanontharit, Ladda Suwitruengrit, Kamonwan Siriwatthanakul, Arunee Thitithanyanont, Anan Jongkaewwattana, Anchalee Avihingsanon, Saranath Lawpoolsri, Watsamon Jantarabenjakul, Eakachai Prompetchara, Lina Hong, Bunruan Sopa, Supalak Phonphithak, Wassana Wijagkanalan, Kiat Ruxrungtham, Hong Thai Pham, Apichaya Khlaiphuengsin, Sasiwimol Ubolyam, Drew Weissman, Mohamad‐Gabriel Alameh, Sorachai Nitayaphan, Prapaporn Savaraj, Chutitorn Ketloy, Vitoon Vonghangool, Nuchtida Phongam, Supranee Buranapraditkun, Siriwan Thongthip, Siriluck Teerachia, Suda Punrin, Naruporn Kasipong, Mijo Samija, Thanakan Rachpradit, Kanipha Sriphraram, Nittaya Boonnak, Palida Pingthaisong, T. Tantawichien, Thanyawee Puthanakit, Wanida Wichaisak, Kwanhathai Chaiprom, Chomnid Shanyib, Supapit Horpratum, Papassorn Kingklao, Angwara Jintabunditwong, Kanchana Prasith, Aphakan Klinsukontakul, Chiratchaya Pornpipatkarn, Nuttamon Siripong, Supasek Laosuebsakul, Nongluk Ratmanee, Ratmanee Puttasuwan, Jirapohn Onaree, Nitiya Tarun, Nattiya Arthonchaikul, Saowarot Chaimala, Chanitra Kohloi, Yupadee Jareonsawad, Decha Puangbaidee, Prach Chinnarat, Apichaya Wattanasathean, Kannika Damkoengkhachonwong, Ketkanhok Nisungnoen, Tharini Sisupha, Wichai Sritangkum, Jesada Sathainsoontorn, Woranut Suksotkhiao, Nanthida Wonglertnirant
article en

Abstract

Covid-19 Pandemic Emergency Fund granted by Thailand's National Economic and Social Development Council provided major funding. Supplementary funding was provided by National Vaccine Institute (NVI), Thailand; Center of Excellence in Vaccine Research and Development (Chula VRC), Faculty of Medicine, Chulalongkorn University; Chulalongkorn University Second Century Fund (C2F); BioNet-Asia and Public Donation through Covid-19 vaccine development fund of the Faculty of Medicine, Chulalongkorn University and the Thai Red Cross Society, Thailand.

The Lancet Regional Health - Southeast AsiaVol. 40
Thai Red Cross Society (TH), National Science and Technology Development Agency (TH), Children's Hospital of Philadelphia (US), Chulalongkorn University (TH), Queen Saovabha Memorial Institute (TH), Mahidol University (TH), King Chulalongkorn Memorial Hospital (TH), Armed Forces Research Institute of Medical Science (TH), HIV Netherlands Australia Thailand Research Collaboration (TH), Mahidol Oxford Tropical Medicine Research Unit (TH), European Organization for Nuclear Research (CH), University of Pennsylvania (US), National Center for Genetic Engineering and Biotechnology (TH)
Chulalongkorn University, Faculty of Medicine, Chulalongkorn University
Openalex Percentile: Top 74%
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.